OQ: Vulvar Cancer Flashcards

1
Q

When do you do SLND. False negative rate. Do you do both sides. How do you do it.

A

o <4 cm, clinically normal nodes, no prior surgery to groin/vulva, experience with SLN

o FNR- GOG 173: 8%, <4cm FNR 2%, GROINS-VI: 6%

o Risk of relapse for false neg node <3%

o Both sides - no, ipsilateral, same indications as IFLND

o How - Tc99 (1cc 2-3hrs prior), isosulfan blue 1% 3-4cc, peritumoral injection at 2, 5, 7, 10 oclock, 30 min prior, make incision over hotspot, send for ultrastaging, do prior to vulvectomy

o Tc99 half life 6 hrs

o If ipsilateral SLN is pos then do contralateral groin dissection or RT

o if SLN positive - see Vulva 4 NCCN.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Stage II vulvar cancer – how do you decide who to resect versus giving radiation therapy versus neodajuvant chemo RT?

A

o Preserving urethra, anus and can I get negative margins

o Depends on performance status and comorbidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the evidence for neoadjuvant chemo RT for vulvar cancer? What is the evidence? Are there specific trials or is it just extrapolated from cervix?

A

o GOG 101

§ cis + 5-FU +RT (split course, 47 Gy)

§ NGR 48%, Complete path response 70%

Everyone gets surgery.

§ Gross residual 52% but 85% had complete resection, neg margins

§ 3% unresectable

§ 33% recurrence rate

o GOG 205

§ Cis 40 wkly + RT (57 Gy)

§ IFLND pre-op if resectable or non suspicious (???) - if negative then exclude inguinal node XRT

§ NGR 64%, Complete path 78%

§ 76% 2yr DFS

§ 38% recurrence rate, 55% wound complication rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What do you do if pt appears to have had a complete clinical response?

Why do you do lots of biopsies?

If confirmed complete pathologic response what do you do?

What’s rate of wound breakdown if you do resection in radiated pt?

A

Lots of biopsies to look for recurrence and determine pathologic response and potentially diagnose microscopic residual disease. If confirmed CR you observe. Wound breakdown rate with resection is 55% from GOG 205.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How would you close a large defect after vulvar resection extending into the distal vagina.

A

o Rhomboid, Martius flap - small defect

o Gracilis, V-Y, TRAM/VRAM - larger: I would have plastics do a gracilis most likely.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the risk of lymphedema after groin dissection versus sentinel lymph node?

A

25% vs 1.9% (GROINSS-V)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

You do a radical vulvectomy for someone with a 3 cm vulvar tumor, sentinel lymph node is positive. How do you manage positive sentinel lymph node?

A

o <= 2 mm, radiation therapy; > 2 mm, full IFLND

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nodes – who gets lymphadenectomy for vulvar cancer? Unilateral or bilateral nodes? Deep or superficial?

A

o criteria for SLN - unifocal, < 4 cm, clinically + radiologically negative node, no prior surgery of vulva / groin

o indication for uniliteral SLN / IFLND - 1) primary lesion < 2 cm; 2) lateral lesion (>= 2 cm from midline); 3) no palpable inguinofemoral lymph nodes

If ipsilateral groin is positive, the contralateral groin should be evaluated surgically and/or treated with EBRT. In select cases of a single, small volume, unilateral, positive inguinal node with a well-lateralized primary tumor <= 2cm and depth of invasion <=5mm and with a clinically negative contralateral groin examination, a contralateral inguinofemoral lympadenectomy or radiation may be omitted. VULVA-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Do you just debulk grossly involved groin nodes or perform complete bilateral IFLND?

A

Hyde retrospective: “Forty patients from three separate databases who met these criteria were identified. Patients were treated either by a full inguino-femoral lymphadenectomy or by a debulking of the clinically involved inguinal lymph nodes. All patients received adjuvant radiotherapy to the groins. In these two groups, there was no difference in groin recurrence rate expressed as groin recurrence-free survival (P= 0.247). In a univariate analysis, both overall and disease-free survival were better in the group of patients treated by nodal debulking. However, in a multivariate analysis, other variables such as extracapsular growth were independent predictors for survival while the method of surgical dissection for the groin had no independent significant impact on survival.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How deep do you inject for sentinel lymph node?

A

o Intradermal. Technique (GROINSS-V protocol: The day before the operation or the morning of the day of the operation, 0.5 mL 30-100 MBqof 99m Tc-labeled nanocolloid with particle size < 80 nm is injected circumferentially intradermally on 4 locations around the primary tumor (each 0.05 mL 15 MBq 99m Tc-labeled nanocolloid). On the day or the afternoon after the injection of the radioactive trcer, following induction of anesthesia, 0.5-1 mL of the blue dye (Lymphozurin or Patent Blue V) is injected intradermally on the same 4 locations around the primary tumor approximately 5-10 minutes prior to the surgical proceudre.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

· Pt with bulky vulvar tumor, evidence of positive pelvic node, what do you do.

A

o Depends on ability to get margins/anus/urethra and symptoms

o Resect any nodes >2cm

o Generally would do cis/RT first and biopsy and resect residual to allow for smaller surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Histology - how do you measure the depth of invasion in vulvar cancer?

A

The depth of stromal invasion is currently defined as the measurement (in millimeters of the tumor from the epithelial-stroma junction of the most adjacent superficial dermal papilla to the deepest point of invasion).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Picture of bony pelvis with lines drawn through it. Describe radiation fields for inguinal and pelvic radiation. what are the doses for radiation therapy of vulvar cancer? What dose to what area.

A

o (1.8 Gy/fx)

o NCCN:

§ Gross primary disease = 60-70 Gy

§ 1’ surgical bed (postop, neg margins) = 45-50 Gy

§ 1’ surgical bed (postop, close/positive margins) = 54-60 Gy

§ Uninvolved LN 45-50 Gy

§ Inguinal LN (positive but no extracapsular extension, no gross residual dz) = 50-55 Gy (pelvis + groin 50.4 Gy + boost to node)

§ Inguinal LN (extracapsular extension) = 54-64 Gy

§ Gross residual or unresectable LN 60-70 Gy

o Close margins - scar + 2cm margin = 54 Gy

o Microscopic margin/residual = 60 Gy

o NACT - 50 Gy → CR → bx

§ Boost 9 Gy if PR + resectable

§ Boost 18 Gy if PR/no response and unresectable up to 65 Gy

o If pos inguinals→ treat pelvis 45 Gy to to external/internal iliacs

o Nodes are 3-5 cm below skin, use CT to determine femoral vessel level and use this depth

o 3D:

§ Inguinals get 6mV low energy AP which spares 1.5 cm so you won’t miss superficial groin nodes

§ PA gets high energy (18 or 25 mV) to spare buttocks to 3cm

o Can also use electrons to boost nodes

o Also use IMRT to contour to gross tumor volume and clinical target volume

o Borders

§ Superior- inferior SI joint and extends horizontal line to ASIS (no higher than L4-L5 unless pelvic nodes involved otherwise 5 cm above + node)

§ Inferior- 2cm below border of tumor

§ Lateral- ASIS vertical line

§ Medial- 2 cm lateral to midline/obturator foramen

o IMRT borders/CTV

§ Extends laterally from femoral vessels to medial border of sartorius and rectus femoris muscles

§ Posteriorly to anterior vastus medialis muscle

§ Medially to pectineus muscle or 2.5-3 cm medialls from the vessels

§ Anterior sartorius muscle

§ Caudal is lesser trochanter of femur

o IMRT pelvic node CTV

§ Bilateral ext iliac, obturator, internal iliac regions with minimum of 7mm expansion to bone and muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

·What is the organ you tried to protect from your radiation field in vulva?

A

Femoral head.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

After surgery, pt with 2 positive groin nodes, what adjuvant radiation do you give?

A

o If resected, 50.4 Gy to groin and pelvis plus boost to inguinal LN bed and 45 Gy to pelvis if PET negative

o Cisplatin sensitization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Recurrent metastatic disease: What do you do for isolated nodal recurrence? Does resecting the node change prognosis?

A

o Resect it, especially if not prior RT and then give RT to treat

o If prior RT–>chemo

o Overall prognosis is poor, almost all are fatal (>80%)

17
Q

What are the borders of femoral triangle, describe the anatomy.

A

Sartorius muscle laterally, inguinal ligament superiorly, adductor longus medially.

· Floor - pectineus. superficial lymph nodes and deep nodes separated by cribriform fascia.

· What are the vessels encountered in the inguinal lymph node dissection?

· femoral A, V, greater saphenous vein

· from lateral to medial: 1) superficial circumflex iliac a/v, superficial epigastric a/v, superficial external pudendal a/v

18
Q

Dictate inguinal lymph node dissection

A

Morrow (key points):

  1. position in low lithotomy. minimize hip flexion to flatten the groin. rotate thigh a few degrees outward. place foley.
  2. make groin incision 8-10cm long in inguinal crease. after palpating adductor longus muscle, carry incision down to but not through the fascia of the sartorius. Use index finger to make subcutaneous tunnel over adductor fascia and sartorius fascia. tunnels converge at the apex of the femoral triangle over the fascia lata.

Surgical priciples and relevant anatomy

· Incision 2 cm below and parallel to inguinal ligament, ending 4 cm lateral to pubic tubercle

· The goal is to remove superficial LNs below Camper’s and above cribriform fascia (continuation of fascia lata over fossa ovalis).

· Femoral LNs found after cribiform fascia incised and

· primarily medial to femoral vein

· Boundaries: inguinal ligament, adductor longus, sartorius, caudally to 2 cm above Hunter’s canal.

· Vessels ligated - superficial external pudendals, superficial epigastrics, and superficial circumflex iliacs

· Saphenous – may preserve or sacrifice

· Consider sartorius transposition in previously irradiated pts any other high risk factor for wound breakdown if IFLND

· Close in 2 layers and place closed-suction drain

From Williams Gynecology -

  1. Anethesia and patient positioning

· Legs are placed in Allen stirrups in low lithotomy position, are abducted approximately 30 degrees, and flexed minimally at the hip to flatten the groin

· Rotation of the thigh a few degrees outward will open the femoral triangle.

  1. Skin incision

· The 8-10 cm incision is made 2 cm below and parallel to the inguinal ligament, starting 3 cm distal and medial to the ASIS – aiming toward the adductor longus tendon.

  1. Developing the upper flap

· Dissect through the subcutaneous fat and Scarpa’s fascia until aponeurosis of the external oblique muscle is encountered.

· The nodal tissue dissected away from the aponeurosis by retracting inferiorly and medially.

· During the dissection, superficial circumflex iliac vessels, superficial epigastric vessels, and superficial external pudendal vessels are encountered and ligated / divided

· Dissection proceeds until the lower margin of the inguinal ligament is exposed.

  1. Developing the lower flap

· The femoral triangle is bordered by inguinal ligament superiorly, by the sartorius muscle laterally, by the adductor longus muscle medially.

· Use blunt finger dissection along the inner portion of the sartorius and adductor longus muscles to help develop the lower flap boundaries

· The dissection is performed through the subcutaneous tissue of the thigh, but remains above fasica lata

· The dissection is continued circumferentially toward the fossa ovalis.

  1. Removal of superficial nodes

· The saphenous vein is encountered during the dissection of the medial side of the fat pad.

· Circumferential dissection is performed to isolate and remove nodal bundle as it exits the fossa ovalis. The remaining attachment are dissected from the cribriform fascia.

  1. Removal of deep nodes

· The deep groin nodes are located just medial and parallel to the femoral vein. Cloquet node is the uppermost.

· The residual deep femoral nodal tissue is excised by removing any fatty tissue along the anterior and medial surfaces of the femoral vein above the lower limit of the fossa ovalis.

  1. (optional) satorius muscle transposition

· The fascia later is incised and blunt dissection of the sartorius muscle is performed

· The proximal sartorius muscle is transected at it insertion to the ASIS

· The transection should be as high as possible with care taken to avoid lateral femoral cutaneous nerve

· The muscle is further mobilized to cover the femoral vessels and sutured to cover the ligament ligament with a 2-O delayed absorbable suture.

19
Q

Picture of vulvar melanoma. How do you treat? What is the treatment for a small vulvar melanoma? Do you do nodes? Does it provide survival benefit? Treatment if nodes are positive?

A
  • WLE, 0.5 cm margin for Tis, 1 cm margin for T1, 2 cm margin for T2 and above.
  • SLN for T1b and above, no completion or contralateral IFLND.

Stage I-II generally observed.

Stage III (node positive, mostly):

if BRAF-, then Nivo monotherapy

if BRAF+, these days many people still treated as if BRAF-, better duration responses, but BRAF/MEK inhibitor is a possibility.

Stage IV (distant): Nivo/Ipi dual therapy

20
Q

Multifocal pulmonary recurrence of melanoma. How do you treat?

A

o CHECKMATE67- ipi/nivo, pembro, BRAF1 - debrafenib, MEK inhibitor- tremetinib, interferon.

o Traditinal chemo

o Keynote 006: Pembro- 34% RR, 1yr OS 74%

o Checkmate 66- nivo vs. chemo - improved PFS, OS in unresectable stage III/IV

o Checkmate 67- HR for death nivo/ipi vs ipi .55 in advanced untreated. OS 3 yrs 58% in combo, 52% nivo alone, 34% ipi alone. Responses regardless of PDL1 status

21
Q

Vulvar melanoma - what are the common mutations

A

BRAF V600E, CKIT, NRAS